Bundred N, Porta N, Brunt AM, Cramer A, et al. Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results. Clin Cancer Res 2022 Feb 14. pii: 1078-0432.CCR-21-3177.
PMID: 35165099